The review will explore aspects related to the implementation and delivery of the Program, as well as the outcomes achieved for consumers, providers, and the broader healthcare system.
As part of the review, Deloitte are seeking input from GPs and practice nurses relevant to bowel cancer screening via a short survey.
For those who were unable to participate due to the constrained time frames, the closing date for the survey has been extended to Friday 5 February 2021.
The survey will take approximately 10-20 minutes to complete. Deloitte will not be collecting any personal information. Responses will not be identifiable, as the data will be reported to the Department at an aggregate thematic level.
Please click the following link to commence the survey: Take me to the survey.
If you have any questions or comments about the survey, please contact the Deloitte team at nbcspreview@deloitte.com.au
